Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Cubicin (daptomycin) / Merck (MSD)

NCT01219114: Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use

Withdrawn

N/A

200

RoW

AstraZeneca

Complicated Skin and Skin Structure Infections and Bacteremia Including Right-sided Endocarditis

10/13

11/13

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites